CEUS adds to locoregional therapy for liver disease
Contrast-enhanced ultrasound (CEUS) can improve locoregional therapy for treating metastatic disease of the liver, according to early study results presented April 10 at UltraCon.
In her presentation, PhD candidate Corinne Wessner from Thomas Jefferson University in Philadelphia, PA, highlighted initial findings from her team’s ongoing work suggesting that microbubble destruction from CEUS triggering is safe and well-tolerated among patients with intrahepatic cholangiocarcinoma (ICC) and metastatic liver disease who also receive transarterial radioembolization with yttrium-90 (Y90-TARE).
“When we add the ultrasound-t...
Source: AuntMinnie.com Headlines - April 11, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Hepatic Infusion Pumps: New Enthusiasm for an Old Technology Hepatic Infusion Pumps: New Enthusiasm for an Old Technology
Patients with advanced, unresectable cholangiocarcinoma had significantly better survival outcomes after treatment with hepatic arterial chemotherapy infusion pumps vs standard therapy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 23, 2024 Category: Gastroenterology Tags: Hematology-Oncology Source Type: news
HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinoma
(MedPage Today) -- SAN FRANCISCO -- Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA), according to results from a... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - January 21, 2024 Category: Gastroenterology Source Type: news
Hospice nurse shares three common symptoms of bile duct cancer - ‘go to the doctor’
Many people don't go to the doctor for these symptoms because they're "general and generic". (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2024 Category: Consumer Health News Source Type: news
Research fuels advances in bile duct cancer care
Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often diagnosed in later stages, making it more difficult to treat, and cases in the U.S. are increasing. In a review article published in Nature Reviews Clinical Oncology in 2023, lead author Sumera I. Ilyas, M.B.B.S., and co-authors share advances in diagnosing, staging and treating bile duct cancer. Dr.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 13, 2024 Category: Databases & Libraries Source Type: news
Mark Shelmerdine, BAFTA L.A. Co-Founder and Producer Who Revived London Films, Dies at 78
Mark Shelmerdine, the BAFTA L.A. co-founder and producer who is credited with reviving Alexandra Korda’s London Films, died Oct. 26 in Santa Barbara after a long illness. He was 78. Shelmerdine was diagnosed with a rare form of bile duct cancer in 2016. After being treated in a trial program…#markshelmerdine #baftala #alexandrakordas #londonfilms #santabarbara #shelmerdine #houston #taylorclark #robertclark #abccinema (Source: Reuters: Health)
Source: Reuters: Health - December 2, 2023 Category: Consumer Health News Source Type: news
Drug Trials Snapshot: LYTGOBI
LYTGOBI is a drug used for the treatment of adults with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that has spread to other parts of the body (metastatic) or cannot not be removed by surgery (unresectable). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Consumer Health: Liver cancer -- risk factors and prevention
October is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you can do to prevent it. More than 41,000 new cases of primary liver cancer and intrahepatic bile duct cancer will be diagnosed in the U.S. this year, and nearly 30,000 people will die of these diseases, according to the American Cancer Society. Liver cancer is cancer that begins in the cells of your liver, which… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 12, 2023 Category: Databases & Libraries Source Type: news
Dad diagnosed with bile duct cancer shares first signs - one symptom occurred at work
Dad-of-two Andrew Clay was on holiday in Devon when he first experienced strange symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - October 4, 2023 Category: Consumer Health News Source Type: news
Antibody Treatment Could Fight Rare But Deadly Bile Duct Cancers
MONDAY, June 12, 2023 -- Patients with bile duct cancer might soon have an additional treatment available to them, thanks to a newly discovered tumor target.
Some bile duct cancers are driven by a mutated HER2 gene, which has also been implicated in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 12, 2023 Category: General Medicine Source Type: news
Antibody Treatment Zanidatamab Could Fight Rare But Deadly Bile Duct Cancers
MONDAY, June 12, 2023 -- Patients with bile duct cancer might soon have an additional treatment available to them, thanks to a newly discovered tumor target.
Some bile duct cancers are driven by a mutated HER2 gene, which has also been implicated... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 12, 2023 Category: General Medicine Source Type: news
Dad, 35, dies from rare cancer just SIX days after marrying mother of his two kids
Chris McGinnis, from Nottinghamshire, was diagnosed with metastasis cholangiocarcinoma, a rare form of bile duct cancer, in February. (Source: the Mail online | Health)
Source: the Mail online | Health - May 17, 2023 Category: Consumer Health News Source Type: news
John Refoua Dies: ‘Avatar’ Film Editor Was 58
John Djahanshah Refoua, a film editor that worked on Avatar and Avatar: The Way of Water, has died. He was 58. Refoua had been diagnosed with a rare bile cancer called cholangiocarcinoma, his wife Serena Refoua confirmed. “Dear friends, my brilliant, sweet, creative husband John Djahanshah Refoua…#johndjahanshahrefoua #avatar #wayofwater #refoua #serenarefoua #serena #jamescamerons #averysophia #magnificentseven2016 #equalizer (Source: Reuters: Health)
Source: Reuters: Health - May 17, 2023 Category: Consumer Health News Source Type: news
Patients Needed for New Mesothelioma Clinical Trial
A new investigational drug for mesothelioma can now begin human trials after it was granted fast-track designation by the U.S. Food and Drug Administration last week. The novel treatment, SnyKIR-110, is a T-cell therapy designed to treat patients with mesothelioma, cholangiocarcinoma (bile duct cancer) and ovarian cancer.
“We are thrilled to receive fast-track designation from the FDA,” said Dr. Bryan Kim, co-founder and CEO of Verismo Therapeutics. “This designation is an important milestone in our efforts to bring this potentially life-saving drug to patients who are in need of new treatment option...
Source: Asbestos and Mesothelioma News - April 19, 2023 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Mesothelioma Source Type: news
Liver Transplants for CRC Metastases: Coming Into Its Own? Liver Transplants for CRC Metastases: Coming Into Its Own?
Although still controversial, transplantation is gaining traction as a treatment option for patients with colorectal liver metastases and intrahepatic cholangiocarcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
